Outcomes after Plerixafor Plus FLAG-IDA (PLERIFLAG) Versus FLAG-IDA +/- Gentuzumab for Adult Patients with First Relapsed/Refractory AML: A Propensity Score Analysis from the Pethema Registry

Juan Miguel M. Bergua Burgues, Isabel Cano-Ferri (Co-author), David Martínez-Cuadron (Co-author), Blanca Boluda (Co-author), Pilar Martínez-Sánchez (Co-author), Rebeca Rodríguez-Veiga (Co-author), Jordi Esteve (Co-author), Susana Vives (Co-author), Josefina Serrano (Co-author), Maria-Belen Vidriales (Co-author), Olga Salamero (Co-author), Carlos Carretero (Co-author), Ana Jimenez-Ubieto (Co-author), Ignacio Casas (Co-author), Rocio Cardesa (Co-author), Marina Diaz-Beyá (Co-author), Salut Brunet (Co-author), Celina Benavente (Co-author), Jose Antonio Pérez-Simón (Co-author), Federico Moscardo (Co-author)Eliana Aguiar (Co-author), Manuel Perez Encinas (Co-author), Aurelio López Martínez (Co-author), Carlos Rguez (Co-author), A. Cabello (Co-author), Jorge Labrador (Co-author), Lissette Del Pilar Costilla (Co-author), Claudia Sossa (Co-author), Teresa Bernal Del Castillo (Co-author), Miguel A. Sanz (Co-author), Pau Montesinos (Co-author)

Research output: Articles / Notes › Scientific Article › peer-review

Original languageUndefined/Unknown
JournalBlood
DOIs
StatePublished - 13 Nov 2019

Research Areas UNAB

  • Medicina Interna

Access to Document

Cite this